Real-Life Multicentre Study on 547 Patients Affected By Waldenstrom Macroglobulinemia Treated with Chemo-Immunotherapy: Which Is the Best and Most Used First-Line Treatment?Francesco Autore, Luca Laurenti, Alessandra Tedeschi et al.|Blood|2023Cited by 0
Ibrutinib or Chemo-Immunotherapy As Second Line Treatment in Waldenstrom Macroglobulinaemia? a Real-Life Multicentre StudyFrancesco Autore, Luca Laurenti, Emanuele Cencini et al.|Blood|2024Cited by 0
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian studyF. Autore, Luca Laurenti, Alessandra Tedeschi et al.|Blood Advances|2026Cited by 0